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Introduction: Erectile dysfunction (ED) is a common problem in men. We have
previously shown that ED is prevalent in patients with CF. It has a signiﬁcant impact
on self-conﬁdence, quality of life and interpersonal relationship. Its aetiology in CF
is postulated to be multi-factorial but not clearly deﬁned.
Aim: To identify the aetiology of ED in CF.
Methods: A self-reporting questionnaire using the International Index of Erectile
Dysfunction (IIEF-5) was distributed to male CF patients >20 years of age in the
outpatient clinic between October and December 2010. IIEF-5 identiﬁes 5 domains
of sexual health consisting of erectile conﬁdence, erection ﬁrmness, maintenance
frequency, maintenance ability and intercourse satisfaction. ED is classiﬁed into 5
severity levels: none, mild, mild to moderate, moderate and severe.
Results: There were 106 eligible patients. 60 patients were issued with the
questionnaire and there were 54 (90%) participants. 16 patients (29.6%) were found
to have ED, of whom 12 (75%) had mild ED, 1 (6.25%) had mild to moderate ED
and 2 (12.5%) had severe ED. CF related diabetes (CFRD) was signiﬁcantly more
prevalent in the ED group compare to the non-ED group (p-value = 0.0047). There
was no difference in terms of age, FEV1% predicted, liver disease status, body
mass index and testosterone levels between the 2 groups.
Discussion: This survey showed that ED is more prevalent in patients with CFRD.
The relationship between ED and CFRD is likely to be attributed to micro vascular
and neurological complications of diabetes. Therefore ED should be routinely
assessed as part of CFRD annual review such that appropriate therapy can be
offered to the sufferers.
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Objectives: To develop a measure of eating attitudes and behaviours (EAB) in cystic
ﬁbrosis (CF), examine its psychometric properties and conduct initial validation
analyses.
Implications: There are no current measures of EAB suitable for use in the CF
population. Once this measure has been fully validated, it can be used clinically as
a general measure of EAB in CF. This will be particularly useful given the serious
health consequences of poor nutritional status (likely to be related to EAB) in CF
and may help to guide treatment planning (i.e. specialist eating disorder service or
in-house management by CF team).
Methods: An initial item generation and piloting stage involved literature searches
of EAB in CF and eating disorders and how they are measured, consultation with
professionals and cognitive interviewing with 8 individuals with CF. The ﬁnal
measure was then administered to 150 participants with CF (11−65 years) recruited
from tertiary CF clinics, who are representative of the wider CF population.
Participants also completed a series of questions about adherence to other treatments
and an existing measure of EAB used in the general population. Other clinical and
demographic information was gathered from participants’ notes.
Conclusions: A ﬁnal measure was developed using standard statistical analyses for
assessing the reliability of a measure (exploratory factor analysis and Cronbach’s
alpha analyses). Preliminary validation of the measure was carried out by examining
its relationships with hypothetically related variables such as clinical status (lung
function), body mass index (BMI), adherence and the existing EAB measure.
